<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1462967/" ref="ordinalpos=1705&amp;ncbi_uid=657139&amp;link_uid=PMC1462967" image-link="/pmc/articles/PMC1462967/figure/f7/" class="imagepopup">Figure 7.  From: ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency. </a></div><br /><div class="p4l_captionBody">Model of the ATM–Chk2–p53 signaling pathway upon Brca1 mutation-associated premature aging and tumorigenesis. ATM–Chk2–p53 signaling pathway senses DNA damage/genomic instability and acts as a gatekeeper to eliminate mutations, but, as a side effect, it may also lead to premature aging.</div></div>